Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Jounce Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 85
- −14 vs. Q3 2022
- Shares held
- 35.9M
- −5.94M (−14.2%) vs. Q3 2022
- Total value
- $39.8M
- −$58.1M (−59.3%) vs. Q3 2022
- New holders
- 10
- 25 more added
- Sold out
- 24
- 30 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JNCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $917.8K |
| Q1 2023 | 84 | $64.1M |
| Q4 2022 | 85 | $39.8M |
| Q3 2022 | 102 | $99.5M |
| Q2 2022 | 102 | $129.3M |
| Q1 2022 | 113 | $287.1M |
| Q4 2021 | 124 | $342.9M |
| Q3 2021 | 115 | $270.6M |
| Q2 2021 | 130 | $244.8M |
| Q1 2021 | 124 | $378.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Jounce Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,177−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Bender Robert & Associates | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −6,400−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −3,420−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,334−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −484−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| TRV GP II, LLC | – | – | – | – | Not filed |
| Jefferies Group LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |